BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 18645304)

  • 1. Squamous cell carcinoma with clear cells: how often is there evidence of tricholemmal differentiation?
    Dalton SR; LeBoit PE
    Am J Dermatopathol; 2008 Aug; 30(4):333-9. PubMed ID: 18645304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folliculocentric squamous cell carcinoma with tricholemmal differentiation: a reappraisal of tricholemmal carcinoma.
    Misago N; Toda S; Narisawa Y
    Clin Exp Dermatol; 2012 Jul; 37(5):484-91. PubMed ID: 22712857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus of tricholemmal differentiation (tricholemmal carcinoma) within Bowen's disease/carcinoma.
    Misago N; Toda S; Nakao T
    J Dermatol; 2016 Apr; 43(4):439-42. PubMed ID: 26365015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clear cells in cutaneous squamous cell carcinoma].
    Corbalán-Vélez R; Ruiz-Macia JA; Brufau C; López-Lozano JM; Martínez-Barba E; Carapeto FJ
    Actas Dermosifiliogr; 2009 May; 100(4):307-16. PubMed ID: 19463234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricholemmoma and clear cell squamous cell carcinoma (associated with Bowen's disease): immunohistochemical profile in comparison to normal hair follicles.
    Misago N; Toda S; Narisawa Y
    Am J Dermatopathol; 2012 Jun; 34(4):394-9. PubMed ID: 22452951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
    Tran TA; Muller S; Chaudahri PJ; Carlson JA
    J Cutan Pathol; 2005 Jan; 32(1):2-11. PubMed ID: 15660649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature.
    Ricci C; Dika E; Di Nanni DD; Zannetti G; Lambertini M; Corti B
    Acta Histochem; 2019 Aug; 121(6):765-767. PubMed ID: 31230705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tricholemmal keratosis and tricholemmal cancer].
    Grouls V
    Hautarzt; 1987 Jun; 38(6):335-41. PubMed ID: 3654204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-histologic characteristics of spinocellular carcinoma of the skin].
    Stojanović S; Poljacki M; Vucković N; Tasić S
    Med Pregl; 1998; 51(1-2):61-7. PubMed ID: 9531777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichogerminoma.
    Tellechea O; Reis JP
    Am J Dermatopathol; 2009 Jul; 31(5):480-3. PubMed ID: 19542926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
    Kanoh M; Amoh Y; Sato Y; Katsuoka K
    Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic tricholemmal carcinoma in situ.
    Lin SK; Cassarino DS
    Am J Dermatopathol; 2013 Aug; 35(6):e99-e102. PubMed ID: 23759876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant proliferating trichilemmal tumors with CD34 expression.
    Chaichamnan K; Satayasoontorn K; Puttanupaab S; Attainsee A
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S28-34. PubMed ID: 21280514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade trichoblastic carcinosarcoma.
    Kazakov DV; Vittay G; Michal M; Calonje E
    Am J Dermatopathol; 2008 Feb; 30(1):62-4. PubMed ID: 18212548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
    Silva EG; Young RH
    Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tricholemmal carcinoma. Report of 11 cases].
    Schell H; Haneke E
    Hautarzt; 1986 Jul; 37(7):384-7. PubMed ID: 3744824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
    Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
    Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
    J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.